Natunola Releases Q2 2009 Results



    WINCHESTER, ON, Aug. 11 /CNW Telbec/ - Natunola Health Biosciences Inc.
(TSX-V:NHI) ("Natunola") reports that the sales for the three months ended on
June 30, 2009 was $444,485 as compared to $573,137 for the comparative period
for 2008, which represented a decrease of $128,652 or 22.4%. The decrease in
revenue is due to the decrease in sales in flax and personal care products
during the quarter. As a result, the Company had a net loss of $18,230 or
$0.00 per share for the quarter ended on June 30, 2009 as compared to a net
loss of $44,800 or $0.00 per share for the comparative period for 2008.
    The sales of the Company's flax products decreased by $123,818 or 25.1%
for the quarter ended June 30, 2009 versus the comparative period for 2008.
The decrease is due to fewer shipment of the flax product to a specific
customer. The sales of the Company's cosmetic and personal care products
decreased slightly by $5,425 or 7.8% for the quarter ended June 30, 2009
versus the comparative period for 2008.
    General expenses declined by $73,055 or 11.7% for the first half ended
June 30, 2009 versus the comparative period for the first half ended June 30,
2008. The decrease is due to lower expenses in both sales and marketing and
the research and development cost.
    Gross margins decreased slightly by 4.5% for the first half ended June
30, 2009 versus comparative period for 2008. The decrease in gross margins is
due to the lower sales.
    The sales of the Company's flax products decreased by $439,421 or 43.4%
for the first half ended June 30, 2009 versus the comparative period for 2008.
The sales of the Company's cosmetic and personal care products decreased by
$34,796 or 20.3% for the first half ended June 30, 2009 versus the comparative
period for 2008. As a result of these, the Company recorded a net loss of
$148,835 or -$0.02 per share for the first half ended June 30, 2009 as
compared to a profit of $95,289 or $0.01 per share for the comparative period
for 2008.
    Results showed improvement for the second quarter (ended June 30, 2009)
over results of both the first quarter (ended March 31, 2009) and
correspondence quarter of last year.

    Some of the statements contained in the release are forward-looking
statements, such as estimates and statements that describe the Company's
future plans, objectives or goals, including words to the effect that the
Company or management expects a stated condition or result to occur. Since
forward-looking statements address future events and conditions, by their very
nature, they involve inherent risks and uncertainties. Actual results in each
case could differ materially from those currently anticipated in such
statements.

    
    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this press release.
    
    %SEDAR: 00009761E




For further information:

For further information: Dr. Nam Fong Han, President & CEO, Natunola
Health Biosciences Inc., 661, St Lawrence Street, Winchester, Ontario, K0C
2K0, Tel (613) 774-0008

Organization Profile

Natunola Health Biosciences Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890